Merck Goes for Early Knockout in Calif. Vioxx Case

As the start of Merck's first California trial involving Vioxx fast approaches, the company is seeking to have one of the two consolidated cases thrown out on statute of limitations grounds. The suits are among 1,800 Vioxx cases filed against Merck in California since the company pulled the drug from the market. Attorneys on both sides each got to select a case for trial. A hearing on Merck's motion for summary judgment is scheduled for June 15 and trial is planned for June 21.

This article requires premium access

This article requires premium access to Law.com. Please sign in or subscribe to read the full text.